Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash to Debt No Debt
ZLTQ's Cash to Debt is ranked higher than
88% of the 395 Companies
in the Global Medical Devices industry.

( Industry Median: 1.73 vs. ZLTQ: No Debt )
ZLTQ' s 10-Year Cash to Debt Range
Min: 6.45   Max: No Debt
Current: No Debt

Equity to Asset 0.70
ZLTQ's Equity to Asset is ranked higher than
77% of the 377 Companies
in the Global Medical Devices industry.

( Industry Median: 0.63 vs. ZLTQ: 0.70 )
ZLTQ' s 10-Year Equity to Asset Range
Min: -5.35   Max: 0.89
Current: 0.7

-5.35
0.89
Interest Coverage No Debt
ZLTQ's Interest Coverage is ranked higher than
99% of the 213 Companies
in the Global Medical Devices industry.

( Industry Median: 155.63 vs. ZLTQ: No Debt )
ZLTQ' s 10-Year Interest Coverage Range
Min: 9999.99   Max: 9999.99
Current: No Debt

F-Score: 5
Z-Score: 20.31
M-Score: -2.30
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 4/10

vs
industry
vs
history
Operating margin (%) -8.82
ZLTQ's Operating margin (%) is ranked higher than
56% of the 385 Companies
in the Global Medical Devices industry.

( Industry Median: 6.58 vs. ZLTQ: -8.82 )
ZLTQ' s 10-Year Operating margin (%) Range
Min: -1082.23   Max: -12.76
Current: -8.82

-1082.23
-12.76
Net-margin (%) -8.92
ZLTQ's Net-margin (%) is ranked higher than
57% of the 385 Companies
in the Global Medical Devices industry.

( Industry Median: 5.11 vs. ZLTQ: -8.92 )
ZLTQ' s 10-Year Net-margin (%) Range
Min: -1111.78   Max: -14.09
Current: -8.92

-1111.78
-14.09
ROE (%) -20.80
ZLTQ's ROE (%) is ranked higher than
54% of the 380 Companies
in the Global Medical Devices industry.

( Industry Median: 5.84 vs. ZLTQ: -20.80 )
ZLTQ' s 10-Year ROE (%) Range
Min: -195.78   Max: -28.57
Current: -20.8

-195.78
-28.57
ROA (%) -15.11
ZLTQ's ROA (%) is ranked higher than
54% of the 395 Companies
in the Global Medical Devices industry.

( Industry Median: 3.49 vs. ZLTQ: -15.11 )
ZLTQ' s 10-Year ROA (%) Range
Min: -103.26   Max: -15.33
Current: -15.11

-103.26
-15.33
ROC (Joel Greenblatt) (%) -222.45
ZLTQ's ROC (Joel Greenblatt) (%) is ranked higher than
51% of the 394 Companies
in the Global Medical Devices industry.

( Industry Median: 12.36 vs. ZLTQ: -222.45 )
ZLTQ' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -1849.11   Max: -431.72
Current: -222.45

-1849.11
-431.72
» ZLTQ's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2013

ZLTQ Guru Trades in Q3 2013

Chuck Royce 553,200 sh (-27.69%)
» More
Q4 2013

ZLTQ Guru Trades in Q4 2013

RS Investment Management 978,900 sh (New)
Jim Simons 364,357 sh (New)
Chuck Royce 410,200 sh (-25.85%)
» More
Q1 2014

ZLTQ Guru Trades in Q1 2014

Steven Cohen 481,900 sh (New)
RS Investment Management 1,165,400 sh (+19.05%)
Chuck Royce Sold Out
Jim Simons 67,400 sh (-81.5%)
» More
Q2 2014

ZLTQ Guru Trades in Q2 2014

RS Investment Management 1,348,166 sh (+15.68%)
Steven Cohen 577,600 sh (unchged)
Jim Simons Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with ZLTQ

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)



No Guru Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 14.55
ZLTQ's P/B is ranked lower than
67% of the 418 Companies
in the Global Medical Devices industry.

( Industry Median: 3.30 vs. ZLTQ: 14.55 )
ZLTQ' s 10-Year P/B Range
Min: 1.79   Max: 16.25
Current: 14.55

1.79
16.25
P/S 6.27
ZLTQ's P/S is ranked lower than
56% of the 418 Companies
in the Global Medical Devices industry.

( Industry Median: 3.06 vs. ZLTQ: 6.27 )
ZLTQ' s 10-Year P/S Range
Min: 0.17   Max: 7.17
Current: 6.27

0.17
7.17
EV-to-EBIT -65.09
ZLTQ's EV-to-EBIT is ranked higher than
50% of the 418 Companies
in the Global Medical Devices industry.

( Industry Median: 35.63 vs. ZLTQ: -65.09 )
ZLTQ' s 10-Year EV-to-EBIT Range
Min: -82   Max: -2.8
Current: -65.09

-82
-2.8
Current Ratio 2.87
ZLTQ's Current Ratio is ranked higher than
72% of the 395 Companies
in the Global Medical Devices industry.

( Industry Median: 2.70 vs. ZLTQ: 2.87 )
ZLTQ' s 10-Year Current Ratio Range
Min: 1.09   Max: 8.23
Current: 2.87

1.09
8.23
Quick Ratio 2.15
ZLTQ's Quick Ratio is ranked higher than
73% of the 395 Companies
in the Global Medical Devices industry.

( Industry Median: 2.04 vs. ZLTQ: 2.15 )
ZLTQ' s 10-Year Quick Ratio Range
Min: 0.78   Max: 7.85
Current: 2.15

0.78
7.85

Valuation & Return

vs
industry
vs
history
Price/Net Cash 67.74
ZLTQ's Price/Net Cash is ranked higher than
72% of the 418 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. ZLTQ: 67.74 )
ZLTQ' s 10-Year Price/Net Cash Range
Min: 3.49   Max: 103.21
Current: 67.74

3.49
103.21
Price/Net Current Asset Value 27.25
ZLTQ's Price/Net Current Asset Value is ranked higher than
63% of the 418 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. ZLTQ: 27.25 )
ZLTQ' s 10-Year Price/Net Current Asset Value Range
Min: 3.12   Max: 30.64
Current: 27.25

3.12
30.64
Price/Tangible Book 16.24
ZLTQ's Price/Tangible Book is ranked lower than
66% of the 418 Companies
in the Global Medical Devices industry.

( Industry Median: 5.80 vs. ZLTQ: 16.24 )
ZLTQ' s 10-Year Price/Tangible Book Range
Min: 2.32   Max: 14.86
Current: 16.24

2.32
14.86
Price/Median PS Value 2.50
ZLTQ's Price/Median PS Value is ranked lower than
64% of the 418 Companies
in the Global Medical Devices industry.

( Industry Median: 1.10 vs. ZLTQ: 2.50 )
ZLTQ' s 10-Year Price/Median PS Value Range
Min: 0.09   Max: 2.45
Current: 2.5

0.09
2.45
Earnings Yield (Greenblatt) -1.50
ZLTQ's Earnings Yield (Greenblatt) is ranked lower than
99% of the 269 Companies
in the Global Medical Devices industry.

( Industry Median: 5.10 vs. ZLTQ: -1.50 )
ZLTQ' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0   Max: 0
Current: -1.5

Business Description

Industry: Medical Devices » Medical Devices
Compare: » details
ZELTIQ Aesthetics Inc is a medical technology company. It develops and commercializes medical products such as 'CoolSculpting System' which is a non-invasive product for the selective reduction of body fat.
» More Articles for ZLTQ

Headlines

Articles On GuruFocus.com
ZELTIQ Announces Conference Call and Webcast of Third Quarter 2014 Financial Results to Be Held on O Oct 15 2014 
ZELTIQ(R) Aesthetics Showcasing Its CoolSculpting(R) Procedure at Plastic Surgery The Meeting 2014 Oct 15 2014 
4 Stocks To Buy, 1 To Avoid In 2012 Feb 18 2012 
Weekly CFO Sales Highlight: INFA, DHR, AN, SMTC, ZLTQ Oct 31 2011 


More From Other Websites
Can Fat-Freezer Zeltiq Aesthetics Heat Up Profits? Oct 24 2014
Weakness Seen in Trinity Biotech (TRIB): Stock Tumbles 7.8% Oct 24 2014
ZELTIQ to Present at Investor Conferences in November 2014 Oct 22 2014
ZELTIQ to Present at Investor Conferences in November 2014 Oct 22 2014
Strength Seen in Cerus (CERS): Stock Gains 6.2% Oct 21 2014
ZELTIQ(R) Aesthetics Showcasing Its CoolSculpting(R) Procedure at Plastic Surgery The Meeting 2014 Oct 10 2014
Owens & Minor Seals Medical Action Acquisition; Shares Fall Oct 08 2014
ZELTIQ Announces Conference Call and Webcast of Third Quarter 2014 Financial Results to Be Held on... Oct 07 2014
Insider Trading Alert - ZLTQ, ADSK And MJN Traded By Insiders Oct 07 2014
What Falling Estimates & Price Mean for Unilife (UNIS) Oct 06 2014
Insider Trading Alert - UMBF, ADT And ZLTQ Traded By Insiders Oct 03 2014
Syneron Zaps Stock Analysts’ Fat in Underdog Push Sep 27 2014
Stock Market Video Analysis for Week Ending 9/12/14 Sep 12 2014
ZELTIQ Announces Location and Agenda for 2014 Investor Day Sep 11 2014
ZELTIQ Aesthetics (ZLTQ) Shows Strength: Stock Rises 8.8% Sep 11 2014
ZELTIQ (ZLTQ) Stock: Moving Average Crossover Alert Sep 10 2014
Stock Market Video Analysis 9/5/14 Sep 05 2014
[video] Zeltiq, Gentherm Have Room to Run Says William Blair Fund Manager Sep 03 2014
Zeltiq (ZLTQ) Shares March Higher, Can It Continue? Sep 03 2014
ZELTIQ Aesthetics (ZLTQ) Worth Watching: Stock Adds 10.2% Sep 03 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK